Identifying Mechanisms of Therapeutic Resistance through Serial Blood Sampling in the Germany Liquid Biopsy Sector for 2025
A critical application of liquid biopsy in the German medical community this year involves the real-time tracking of tumor evolution and the emergence of drug resistance. As cancer cells are exposed to targeted therapies, they often develop secondary mutations that allow them to bypass the drug's effect, leading to clinical progression. Serial liquid biopsies allow oncologists to identify these...
0 Commentarii 0 Distribuiri 21 Views 0 previzualizare